Showing results (1-10 of 122) with videos related to
Sort By:
Pageof 13
Frontiers in Immunology|May 21, 2016
Allosteric Modulation of Chemoattractant ReceptorsMarcello Allegretti, Maria Candida Cesta, Massimo LocatiInternational Journal of Molecular Sciences|June 15, 2019
Chemokine Signaling in Chemotherapy-Induced Neuropathic PainLaura Brandolini, Michele d'Angelo, Andrea Antonosante, et al.Immunology Letters|June 16, 2012
Current status of chemokine receptor inhibitors in developmentMarcello Allegretti, Maria Candida Cesta, Alexandre Garin, et al.Biomolecules|June 27, 2024
The History of Nerve Growth Factor: From Molecule to DrugElizabeth Gavioli, Flavio Mantelli, Maria Candida Cesta, et al.Oncotarget|April 19, 2017
Multiple anti-tumor effects of Reparixin on thyroid cancerFederica Liotti, Maria De Pizzol, Marcello Allegretti, et al.Pain and Therapy|September 13, 2022
Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR AxisMaria C Spera, Maria C Cesta, Mara Zippoli, et al.Trends in Pharmacological Sciences|April 22, 2008
Allosteric inhibitors of chemoattractant receptors: opportunities and pitfallsMarcello Allegretti, Riccardo Bertini, Cinzia Bizzarri, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 13, 2023
The immune activity of selective estrogen receptor modulators is gene and macrophage subtype-specific yet converges on Il1b downregulationChiara Sfogliarini, Giovanna Pepe, Candida Maria Cesta, et al.Ophthalmology|April 15, 2018
Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic KeratitisStefano Bonini, Alessandro Lambiase, Paolo Rama, et al.Pharmaceutics|February 25, 2023
Innovation in the Development of Synthetic and Natural Ocular Drug Delivery Systems for Eye Diseases Treatment: Focusing on Drug-Loaded Ocular Inserts, Contacts, and Intraocular LensesLetizia Pelusi, Domitilla Mandatori, Leonardo Mastropasqua, et al.Pageof 13